SERMs: evolutionary chemistry, revolutionary biology.

Abstract:

:Estrogens are known as important modulators of development, growth and maintenance of primary sexual physiology. The medical field has also grown increasingly appreciative of the effects of estrogens on non-traditional target tissues such as bone, cardiovascular tissue and the CNS. Postmenopausal women have been the beneficiaries of estrogen supplementation regimes, but the proliferative actions of estrogens on uterine and breast tissue have raised concerns. Combining estrogens with progestins (HRT) has succeeded in blunting the uterine effects of estrogen but not the effects of estrogens on breast tissue, and breakthrough bleeding induced by HRT regimes continues to present compliance issues. The discovery by Jordan and coworkers in 1987 that the "antiestrogens" tamoxifen and raloxifene showed estrogenic effects in preventing bone loss in ovariectomized rats revolutionized the way we have come to the think of nuclear receptor functioning. Since that time, broad insights have been garnered into both the mechanisms involved in the primary, ligand activated nuclear transcription pathway as well as other, non-traditional pathways via which estrogens may exert their effects. The recent discovery of a second estrogen receptor ERbeta has provided additional possibilities for investigation and therapeutic intervention. Even though raloxifene (Evista) has been approved for the treatment and prevention of osteoporosis in postmenopausal women, there is room for improvement. For example, normal HRT alleviates hot flush and urogenital complaints; raloxifene does neither. In addition raloxifene does not raise overall HDL (while HRT does) but does increase venous thromboembolisms. The ideal SERM will maximize all of the positive estrogen attributes while minimizing the negatives, and to that end, there has been considerable activity in the medicinal chemistry community dedicated towards the modification of the SERM structure to achieve compounds with preferable profiles. What we have witnessed, so far, is an evolutionary march of compounds with potential clinical benefit over raloxifene, although the ideal SERM remains to be realized.

journal_name

Curr Pharm Des

authors

Miller CP

doi

10.2174/1381612023393404

subject

Has Abstract

pub_date

2002-01-01 00:00:00

pages

2089-111

issue

23

eissn

1381-6128

issn

1873-4286

journal_volume

8

pub_type

杂志文章,评审
  • Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors.

    abstract:: ...

    journal_title:Current pharmaceutical design

    pub_type: 社论

    doi:10.2174/1381612825999190515120510

    authors: Deb PK

    更新日期:2019-01-01 00:00:00

  • Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.

    abstract:BACKGROUND:Casein kinase II (CK2) is a pro-oncogenic protein, which is emerging as a promising therapeutic target in cancer. Recent studies have revealed an important role for CK2 in tumorigenesis. High levels of CK2 are noted in many malignancies including leukemia. Use of CK2 inhibitors in various malignancies includ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161006154311

    authors: Gowda C,Sachdev M,Muthusami S,Kapadia M,Petrovic-Dovat L,Hartman M,Ding Y,Song C,Payne JL,Tan BH,Dovat S

    更新日期:2017-01-01 00:00:00

  • Virtual Screening Techniques and Current Computational Infrastructures.

    abstract::The drug discovery process in general is a very resource intensive undertaking that has existed for a very long time. In the last two decades, performing molecular simulations that determine the level of interaction between a protein and ligand have been refined to the point where they are now an essential part of the...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160414142530

    authors: Haga JH,Ichikawa K,Date S

    更新日期:2016-01-01 00:00:00

  • Luminescent G-quadruplex probes.

    abstract::G-quadruplexes have found increasing potential in applications such as molecular therapeutics, diagnostics, and sensing. As a consequence, small molecules capable of selectively detecting G-quadruplexes have received significant attention in recent literature. Our review here addresses representative advances in the d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799958314

    authors: Ma DL,Shiu-Hin Chan D,Yang H,He HZ,Leung CH

    更新日期:2012-01-01 00:00:00

  • Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation.

    abstract::Atrial fibrillation (AF) is a frequent cardiac arrhythmia. It is a common major cause of serious diseases and is an increasing health-care burden. AF is associated with an excess amount of reactive oxygen species. In this review, we summarize several possible reactive oxygen species pathways that induce AF based on at...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180903144042

    authors: Ren X,Wang X,Yuan M,Tian C,Li H,Yang X,Li X,Li Y,Yang Y,Liu N,Shang H,Gao Y,Xing Y

    更新日期:2018-01-01 00:00:00

  • Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact.

    abstract::Aspirin is the cornerstone of treatment in patients with coronary artery disease. However, several studies investigating the in vitro response of platelets to the administration of aspirin showed this response to be variable, with some patients exhibiting non-responsiveness or resistance. Aspirin resistance may be cat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787846964

    authors: Papathanasiou A,Goudevenos J,Tselepis AD

    更新日期:2009-01-01 00:00:00

  • Mitochondrial biogenesis: regulation by endogenous gases during inflammation and organ stress.

    abstract::The influence of mitochondrial dysfunction on pathological states involving inflammatory and/or oxidative stress in tissues that do not show frank cellular apoptosis or necrosis has been rather difficult to unravel, and the literature is replete with contradictory information. Although such discrepancies have many pot...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140306095717

    authors: Suliman HB,Piantadosi CA

    更新日期:2014-01-01 00:00:00

  • High-throughput screening identifies small molecule inhibitors of molecular chaperones.

    abstract::Heat shock proteins (HSPs) are involved in a number of cellular processes, including cell cycle, growth, and survival, apoptosis, stress responses, angiogenesis, and oncogenesis. Among the characterized HSPs, the molecular chaperone HSP90 has emerged as an exciting molecular target for cancer therapy since its discove...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Kondoh Y,Osada H

    更新日期:2013-01-01 00:00:00

  • Inhibitors of HIV-1 entry.

    abstract::Since the discovery of human immunodeficiency virus (HIV) as a causative agent of acquired immune deficiency syndrome (AIDS) various strategies were employed to counter its devastating actions. One such concept relies on the prevention of HIV entry into host's "competent" cells by means of compounds known as entry inh...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319100003

    authors: Micewicz ED,Ruchala P

    更新日期:2013-01-01 00:00:00

  • Small cationic antimicrobial peptidomimetics: emerging candidate for the development of potential anti-infective agents.

    abstract::Rapid increase in the emergence and spread of microbes resistant to conventionally used antibiotics has become a major threat to global health care. Antimicrobial peptides (AMPs) are considered as a potential source of novel antibiotics because of their numerous advantages such as broad-spectrum activity, lower tenden...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990003

    authors: Lohan S,Bisht GS

    更新日期:2013-01-01 00:00:00

  • GnRH in the treatment of Hypogonadotropic hypogonadism.

    abstract::Gonadotropin Releasing Hormone (GnRH) is at the centre of the scientific debate for the treatment of hypogonadotropic hypogonadism. Sexual maturation and reproductive function depend on the pulsatile secretion of GnRH are mainly congenital and may or may not be associated with other genetic anomalies or syndromes. Cli...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201125113319

    authors: Bettocchi C,Rinaldi M,Sebastiani F

    更新日期:2020-11-24 00:00:00

  • Therapeutic effects of micronutrient supplements on sperm parameters: Fact or Fiction?

    abstract:BACKGROUND:Despite the limited evidence about the effect of micronutrient supplementation on the semen quality, many micronutrient supplements have been used to improve male fertility. Approximately, 40%-50% of male infertility cases in general and up to 80% in men with idiopathic infertility cases are caused by oxidat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200415173537

    authors: Dimitriadis F,Tsounapi P,Zachariou A,Kaltsas A,Sokolakis I,Hatzichristodoulou G,Symeonidis EN,Kotsiris D,Gabales MR,Vlachopoulou E,Takenaka A,Sofikitis N

    更新日期:2020-04-15 00:00:00

  • Muscarinic acetylcholine receptors.

    abstract::Muscarinic acetylcholine receptors mediate diverse physiological functions. At present, five receptor subtypes (M(1) - M(5)) have been identified. The odd-numbered receptors (M(1), M(3), and M(5)) are preferentially coupled to G(q/11) and activate phospholipase C, which initiates the phosphatidylinositol trisphosphate...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778522056

    authors: Ishii M,Kurachi Y

    更新日期:2006-01-01 00:00:00

  • DNA-photocleavage agents.

    abstract::This review describes recent advances in the development of DNA-photocleavage agents. Major mechanisms of photosensitized DNA photocleavage are presented and the most popular categories of compounds are considered, which include metal complexes and many organic functional derivatives. DNA-targeted conjugates of photos...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397140

    authors: Da Ros T,Spalluto G,Boutorine AS,Bensasson RV,Prato M

    更新日期:2001-11-01 00:00:00

  • Targeted drugs and nanomedicine: present and future.

    abstract::Packaging small-molecule drugs into nanoparticles improves their bio-availability, bio-compatibility and safety profiles. Multifunctional particles carrying large drug payloads for targeted transport, immune evasion and favourable drug release kinetics at the target site, require a certain minimum size usually 30-300 ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787002870

    authors: Debbage P

    更新日期:2009-01-01 00:00:00

  • Anti-TNF therapy for Crohn's disease.

    abstract::Although the cause of Crohn's disease remains unknown considerable progress has been made in recent years to unravel the pathogenesis of the inflammatory processes seen in chronic idiopathic inflammatory bowel diseases (IBD). Th-1 lymphocytes seem to orchestrate the inflammation through the production of pro-inflammat...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612033391982

    authors: D'Haens G

    更新日期:2003-01-01 00:00:00

  • Acute Rejection Following Kidney Transplantation: State-of-the-Art and Future Perspectives.

    abstract::Although acute renal graft rejection rate has declined in the last years, and because an adequate therapy can improve graft outcome, its therapy remains as one of the most significant challenges for pharmacists and physicians taking care of transplant patients. Due to the lack of evidence highlighted by the available ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200610184433

    authors: Rodrigo E,Chedid MF,Segundo DS,Millán JCRS,López-Hoyos M

    更新日期:2020-01-01 00:00:00

  • Clopidogrel resistance: implications for coronary stenting.

    abstract::Clopidogrel, in combination wih aspirin, is currently the drug of choice to prevent thrombosis after coronary stent implantation. Currently, clopidogrel is administered to the vast majority of patients without any assessment of platelet inhibition. Response variability and resistance, however, definitely occur to clop...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776361345

    authors: Gurbel PA,Lau WC,Bliden KP,Tantry US

    更新日期:2006-01-01 00:00:00

  • New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection.

    abstract::Mitochondria fulfill a number of essential cellular functions, being recognized that the strict regulation of the structure, function and turnover of these organelles is an immutable control node for the maintenance of neuronal integrity and homeostasis. Many lines of evidence posit that mitochondria constitute a conv...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211798072490

    authors: Correia SC,Cardoso S,Santos RX,Carvalho C,Santos MS,Perry G,Smith MA,Moreira PI

    更新日期:2011-01-01 00:00:00

  • Lipid-based Nanocarriers for Cancer and Tumor Treatment.

    abstract::Cancer and tumor have been major reasons for numerous deaths in this century across the world. Many strategies have been designed to treat, diagnose, or prevent cancer. The success of chemotherapy largely depends on drug targeting. The advent of nanotechnology has vastly improved drug delivery for targeting and diagno...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200720235752

    authors: Ansari MT,Ramlan TA,Jamaluddin NN,Zamri N,Salfi R,Khan A,Sami F,Majeed S,Hasnain MS

    更新日期:2020-01-01 00:00:00

  • Recombinant human serum albumin fusion proteins and novel applications in drug delivery and therapy.

    abstract::Fusion proteins have been well-studied and widely applied in biopharmaceutics. Albumin fusion proteins are simple to construct, easy to purify, and stable to formulate. One main application of fusion protein is to extend the plasma half-life of therapeutic proteins and peptides. Albiglutide for diabetes treatment is t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150302120047

    authors: Rogers B,Dong D,Li Z,Li Z

    更新日期:2015-01-01 00:00:00

  • Age-Appropriate Formulations Including Pharmaceutical Excipients in Neonatal Medicines.

    abstract:BACKGROUND:The development of appropriate pharmaceutical formulations for routine neonatal practice is challenging because of the developmental characteristics and the need for it to be specifically ageappropriate. This has led to wide use of extemporaneous formulations, which lack standardized procedures that can resu...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170926122613

    authors: Kogermann K,Lass J,Nellis G,Metsvaht T,Lutsar I

    更新日期:2017-01-01 00:00:00

  • Binge Eating and Binge Drinking: A Two-Way Road? An Integrative Review.

    abstract::Unhealthy diet and alcohol are serious health problems, especially in adolescents and young adults. "Binge" is defined as the excessive and uncontrolled consumption of food (binge eating) and alcohol (binge drinking). Both behaviors are frequent among young people and have a highly negative impact on health and qualit...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612826666200316153317

    authors: Escrivá-Martínez T,Herrero R,Molinari G,Rodríguez-Arias M,Verdejo-García A,Baños RM

    更新日期:2020-01-01 00:00:00

  • Iron oxide nanoparticle-induced oxidative stress and genotoxicity in human skin epithelial and lung epithelial cell lines.

    abstract::Iron oxide (Fe₃O₄) nanoparticles (IONPs) have received much attention for their utility in biomedical applications such as magnetic resonance imaging, drug delivery and hyperthermia. Recent studies reported that IONPs induced cytotoxicity in mammalian cells. However, little is known about the genotoxicity of IONPs fol...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612811319370011

    authors: Ahamed M,Alhadlaq HA,Alam J,Khan MA,Ali D,Alarafi S

    更新日期:2013-01-01 00:00:00

  • Alpha2-antiplasmin on cardiovascular diseases.

    abstract::Circumstantial evidence has been provided of a role of the plasminogen/plasmin system in a variety of biological phenomena, including thrombolysis, vascular stenosis, reproduction, embryogenesis, cell invasion, angiogenesis, brain function and chronic lung or kidney inflammatory disorders. Inhibition of the system occ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776056038

    authors: Matsuno H

    更新日期:2006-01-01 00:00:00

  • Antiviral drugs that target cellular proteins may play major roles in combating HIV resistance.

    abstract::Despite the significant progresses made in antiretroviral therapy, current drugs still cannot cure or prevent HIV infection. And all drugs continue to select for drug-resistant HIV strains. Consequently, new antiretroviral drugs are constantly being developed. To ensure safety, these drugs are usually designed to inhi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043382422

    authors: Provencher VM,Coccaro E,Lacasse JJ,Schang LM

    更新日期:2004-01-01 00:00:00

  • Optimization of cardiac metabolism in heart failure.

    abstract::The derangement of the cardiac energy substrate metabolism plays a key role in the pathogenesis of heart failure. The utilization of non-carbohydrate substrates, such as fatty acids, is the predominant metabolic pathway in the normal heart, because this provides the highest energy yield per molecule of substrate metab...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211798357773

    authors: Nagoshi T,Yoshimura M,Rosano GM,Lopaschuk GD,Mochizuki S

    更新日期:2011-12-01 00:00:00

  • CFTR inhibitors.

    abstract::The cystic fibrosis transmembrane conductance regulator (CFTR) protein is a cAMP-regulated Cl- channel whose major function is to facilitate epithelial fluid secretion. Loss-of-function mutations in CFTR cause the genetic disease cystic fibrosis. CFTR is required for transepithelial fluid transport in certain secretor...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990321

    authors: Verkman AS,Synder D,Tradtrantip L,Thiagarajah JR,Anderson MO

    更新日期:2013-01-01 00:00:00

  • Roles of cardiovascular risk factors in endothelial nitric oxide synthase regulation: an update.

    abstract::Cardiovascular disease remains the number one killer in the United States and many other countries. Each year, there are enormous research efforts on its pathogenesis, prevention and treatment led by scientists worldwide. One of the most significant research areas is the impact and mechanisms of existing or new cardio...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113196660744

    authors: Jamaluddin MS,Liang Z,Lu JM,Yao Q,Chen C

    更新日期:2014-01-01 00:00:00

  • Food addiction and neuroimaging.

    abstract::Obesity has become a serious epidemic and one of the leading global health problems. However, much of the current debate has been fractious, and etiologies of obesity have been attributed to eating behavior (i.e. fast food consumption), personality, depression, addiction or genetics. One of the interesting new hypothe...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161211795656855

    authors: Zhang Y,von Deneen KM,Tian J,Gold MS,Liu Y

    更新日期:2011-01-01 00:00:00